The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease

被引:61
|
作者
Kvartsberg, Hlin [1 ]
Lashley, Tammaryn [2 ,3 ]
Murray, Christina E. [2 ,4 ]
Brinkmalm, Gunnar [1 ,5 ]
Cullen, Nicholas C. [1 ]
Hoglund, Kina [1 ,5 ,6 ]
Zetterberg, Henrik [1 ,3 ,4 ,5 ]
Blennow, Kaj [1 ,5 ]
Portelius, Erik [1 ,5 ]
机构
[1] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad,Sahlgrenska Univ Hospital Molnda, S-43180 Molndal, Sweden
[2] UCL Inst Neurol, Queen Sq Brain Bank Neurol Disorders, Dept Movement Disorders, London, England
[3] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[4] UCL, UK Dementia Res Inst, London, England
[5] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[6] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Dis Res, Neurogeriatr Div, Stockholm, Sweden
基金
瑞典研究理事会; 英国医学研究理事会; 欧洲研究理事会;
关键词
Neurogranin; Alzheimer's disease; Brain tissue; Familial Alzheimer's disease; Mass spectrometry; LONG-TERM POTENTIATION; CEREBROSPINAL-FLUID; AMYLOID-BETA; NATIONAL INSTITUTE; COGNITIVE DECLINE; SYNAPTIC LOSS; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; CALMODULIN; RATIO;
D O I
10.1007/s00401-018-1910-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Synaptic degeneration and neuronal loss are early events in Alzheimer's disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer's disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n=9), fAD (n=10), CU-AP (n=13) and controls (n=9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.
引用
收藏
页码:89 / 102
页数:14
相关论文
共 50 条
  • [1] The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
    Hlin Kvartsberg
    Tammaryn Lashley
    Christina E. Murray
    Gunnar Brinkmalm
    Nicholas C. Cullen
    Kina Höglund
    Henrik Zetterberg
    Kaj Blennow
    Erik Portelius
    [J]. Acta Neuropathologica, 2019, 137 : 89 - 102
  • [2] Prion Protein is Reduced in Aging and in Sporadic but not in Familial Alzheimer's Disease
    Whitehouse, Isobel J.
    Jackson, Carolyn
    Turner, Anthony J.
    Hooper, Nigel M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (03) : 1023 - 1031
  • [3] Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
    Kvartsberg, Hlin
    Portelius, Erik
    Andreasson, Ulf
    Brinkmalm, Gunnar
    Hellwig, Konstantin
    Lelental, Natalia
    Kornhuber, Johannes
    Hansson, Oskar
    Minthon, Lennart
    Spitzer, Philipp
    Maler, Juan M.
    Zetterberg, Henrik
    Blennow, Kaj
    Lewczuk, Piotr
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [4] Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
    Hlin Kvartsberg
    Erik Portelius
    Ulf Andreasson
    Gunnar Brinkmalm
    Konstantin Hellwig
    Natalia Lelental
    Johannes Kornhuber
    Oskar Hansson
    Lennart Minthon
    Philipp Spitzer
    Juan M Maler
    Henrik Zetterberg
    Kaj Blennow
    Piotr Lewczuk
    [J]. Alzheimer's Research & Therapy, 7
  • [5] Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
    Hellstrom-Lindahl, E.
    Viitanen, M.
    Marutle, A.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (04) : 243 - 252
  • [6] Aluminium in brain tissue in familial Alzheimer's disease
    Mirza, Ambreen
    King, Andrew
    Troakes, Claire
    Exley, Christopher
    [J]. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2017, 40 : 30 - 36
  • [7] Brain metabolic differences between sporadic and familial Alzheimer's disease
    Mosconi, L
    Sorbi, S
    Nacmias, B
    De Cristofaro, MTR
    Fayyaz, M
    Cellini, E
    Bagnoli, S
    Bracco, L
    Herholz, K
    Pupi, A
    [J]. NEUROLOGY, 2003, 61 (08) : 1138 - 1140
  • [8] Biomarkers in Sporadic and Familial Alzheimer's Disease
    Lista, Simone
    O'Bryant, Sid E.
    Blennow, Kaj
    Dubois, Bruno
    Hugon, Jacques
    Zetterberg, Henrik
    Hampel, Harald
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (02) : 291 - 317
  • [9] Amyloid Imaging Findings in Familial and Sporadic Patients with Alzheimer's Disease
    Sanlier, M.
    Yilmaz, Y.
    Topcular, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1030 - 1030
  • [10] Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
    Levey, AI
    Heilman, CJ
    Lah, JJ
    Nash, NR
    Rees, HD
    Wakai, M
    Mirra, SS
    Rye, DB
    Nochlin, D
    Bird, TD
    Mufson, EJ
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (06) : 742 - 753